Nannan Wang
Physician · University Eye Associates
Credentials: · · · ·
History
- 2019–Present
University Eye Associates
- 1997–2000
Ophthalmology
- 1996–1997
Preliminary or Transitional Year
UTHealth Houston School of Public Health
- 1992–1996
Research
Proceedings of the National Academy of Sciences of the United States of America · 2004 · First of 5 authors · Corresponding · 843 citations
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
Journal of Biological Chemistry · 2000 · 829 citations
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
Journal of Clinical Investigation · 1997 · 731 citations
86 papers
30 papers
- JT
9 papers · 5 as a resident
9 papers
8 papers
5 papers
5 papers
4 papers
Grants
- 2024–2029
Cellular and Molecular Mechanisms of Atherosclerosis
National Heart, Lung, and Blood Institute · P01
Project lead · $778.5K · Columbia University Health Sciences
- 2019–2028
Atherothrombosis in JAK2V617F Clonal Hematopoiesis
National Heart, Lung, and Blood Institute · R01
Contact PI · $4M · Columbia University Health Sciences
- 2024–2027
The Role of Eosinophil in Thrombosis and Atherosclerosis in LNK Deficiency
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.9M · Columbia University Health Sciences
- 2007–2023
Mechanisms of Atherogenesis in Insulin Resistance
National Heart, Lung, and Blood Institute · P01
Project lead · $1.6M · Columbia University Health Sciences
Clinical trials
- 2018–2020
Impact of LDL-cholesterol Lowering on Platelet Activation
Principal investigator · Terminated · Phase 4
Columbia University